Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa
NCT ID: NCT01174602
Last Updated: 2015-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2009-11-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa
NCT00627341
Food Exposure Therapy in Anorexia Nervosa
NCT00755820
Meal-Based Exposure and Response Prevention in Anorexia Nervosa
NCT03747835
Cognitive Remediation Therapy in Anorexia Nervosa
NCT01772394
Exposure Therapy Study In Adults With Eating Disorders
NCT06171711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure Therapy for AN (AN-EX/RP)
Exposure Therapy and Ritual Prevention (AN-EX/RP) includes 12 sessions of confronting feared eating situations without the use of anxiety reducing behaviors.
Exposure Therapy for AN (AN-EX/RP)
12 Sessions, 3 times per week. 90 minute sessions. Group therapy twice per week.
Cognitive Remediation Therapy
Cognitive Remediation Therapy (CRT)
Cognitive Remediation Therapy
12 Sessions, 3 times per week. 45 minute sessions. Group therapy twice per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure Therapy for AN (AN-EX/RP)
12 Sessions, 3 times per week. 90 minute sessions. Group therapy twice per week.
Cognitive Remediation Therapy
12 Sessions, 3 times per week. 45 minute sessions. Group therapy twice per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects will have achieved 85% of ideal body weight (IBW)
3. Age 16-45 years
4. No acute medical condition
5. Subjects must have signed informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
Exclusion Criteria
2. Substance abuse or dependence in the last 6 months
3. Current Axis I disorder requiring psychotropic medication (ongoing antidepressant treatment for stable comorbid conditions will be allowed)
4. Significant co-morbid depression
5. Significant medical problems that would introduce additional risk related to research or interfere with participation, e.g. SBP\>140, DBP\>90, HR\>100 for a sustained period.
6. Active suicidal intent
16 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
National Alliance for Research on Schizophrenia and Depression
OTHER
The Hilda & Preston Davis Foundation
OTHER
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanna Steinglass, MD
Role: PRINCIPAL_INVESTIGATOR
NYSPI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.